Skip to content
10-Q

Quarterly Report

Fortress Biotech, Inc. FBIO FBIOP

0001104659-25-111989

← back to feed
Filed
Nov 14, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted Q3 2025 · Sep 30, 2025 33.1M sh
Shares Diluted Q3 2025 · Sep 30, 2025 30.7M sh
Shares Diluted Q3 2025 · Sep 30, 2024 19.7M sh
Shares Diluted Q3 2025 · Sep 30, 2024 19.04M sh
Dividends Paid Q3 2025 · Sep 30, 2025 $498K
Dividends Paid Q3 2025 · Sep 30, 2024 $528K
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$53.23M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$67.28M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $86.22M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $57.26M
Cash And Equivalents Q3 2025 · Sep 30, 2024 $58.85M
Stockholders Equity Q3 2025 · Sep 30, 2025 $55.86M
Stockholders Equity Q3 2025 · Dec 31, 2024 $22.74M
Current Liabilities Q3 2025 · Sep 30, 2025 $54.07M
Current Liabilities Q3 2025 · Dec 31, 2024 $71.4M
Total Liabilities Q3 2025 · Sep 30, 2025 $116.22M
Total Liabilities Q3 2025 · Dec 31, 2024 $145.87M
Current Assets Q3 2025 · Sep 30, 2025 $118.5M
Current Assets Q3 2025 · Dec 31, 2024 $90.37M
Total Assets Q3 2025 · Sep 30, 2025 $181.41M
Total Assets Q3 2025 · Dec 31, 2024 $144.22M
Total Assets Q3 2025 · Sep 30, 2024 $127.09M
Eps Diluted Q3 2025 · Sep 30, 2025 $0.11
Eps Diluted Q3 2025 · Sep 30, 2025 $0.14
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.76
Eps Diluted Q3 2025 · Sep 30, 2024 −$2.43
Eps Basic Q3 2025 · Sep 30, 2025 $0.13
Eps Basic Q3 2025 · Sep 30, 2025 $0.16
Eps Basic Q3 2025 · Sep 30, 2024 −$0.76
Eps Basic Q3 2025 · Sep 30, 2024 −$2.43
Sga Expense Q3 2025 · Sep 30, 2025 $17.42M
Sga Expense Q3 2025 · Sep 30, 2025 $81.67M
Sga Expense Q3 2025 · Sep 30, 2024 $21.99M
Sga Expense Q3 2025 · Sep 30, 2024 $60.87M
Net Income Q3 2025 · Sep 30, 2025 $5.85M
Net Income Q3 2025 · Sep 30, 2025 $10.75M
Net Income Q3 2025 · Sep 30, 2024 −$12.87M
Net Income Q3 2025 · Sep 30, 2024 −$39.23M
Operating Income Q3 2025 · Sep 30, 2025 −$6.81M
Operating Income Q3 2025 · Sep 30, 2025 −$65.43M
Operating Income Q3 2025 · Sep 30, 2024 −$22.1M
Operating Income Q3 2025 · Sep 30, 2024 −$86.54M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $5.76M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $15.48M
Cost Of Revenue restated Q3 2025 · Sep 30, 2024 $4.47M
Cost Of Revenue restated Q3 2025 · Sep 30, 2024 $16.2M
Revenue Q3 2025 · Sep 30, 2025 $17.63M
Revenue Q3 2025 · Sep 30, 2025 $47.18M
Revenue Q3 2025 · Sep 30, 2024 $14.63M
Revenue Q3 2025 · Sep 30, 2024 $42.56M